Ibrexafungerp: A First-in-Class Oral Triterpenoid Glucan Synthase Inhibitor

Jallow, S; Govender, NP

Jallow, S (corresponding author), Natl Inst Communicable Dis, Ctr Healthcare Associated Infect Antimicrobial Re, ZA-2131 Johannesburg, South Africa.

JOURNAL OF FUNGI, 2021; 7 (3):

Abstract

Ibrexafungerp (formerly SCY-078 or MK-3118) is a first-in-class triterpenoid antifungal or "fungerp" that inhibits biosynthesis of beta-(1,3)-D-glucan......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索